7-day Infusion set replacement: 7-day infusion set replacement (Experimental arm) In this group, the infusion sets (the tubes and connectors used to deliver medications through the central venous catheter) will be changed once a week, every 7 days. During each replacement, all sets will be disconnected and replaced with new sterile ones.
4-day infusion set replacement: 4-day infusion set replacement (Active comparator arm) In this group, the infusion sets will be changed every 4 days, which reflects the most common international recommendation. The procedure is the same: all sets connected to the central venous catheter will be replaced with new sterile ones. This strategy represents the current standard of care and will serve as the comparison for the 7-day approach.
In the intensive care unit, patients' care and secure drugs administration require a central venous catheter. These invasive devices can lead to complications, particularly infections. Most preventive recommendations focus on catheter insertion, line handling, and dressings. Few recommendations adress catheter dwell time, which is certainly the main source of infection. Part of the prevention strategy is the regular and systematic replacement of infusion sets , as they may become contaminated during use, mainly through the hands of healthcare professionals. Prolonged use increases the risk of infection. Infusion lines changes involve disconnecting the old sets, discarding infusion devices containing drug residues, and replacing them with new sterile devices.
Current international guidelines recommend replacing these sets every 4 days, and the Center for Disease Control and Prevention recommends not exceeding 7 days. Replacing these devices requires the time of qualified nurses, numerous sterile medical devices, and medications. In addition to the intended effect on infection prevention, the procedure has impacts on workload and costs.
The objective of the study is to demonstrate that changing infusion set every 7 days does not increase the rate of central venous catheters related infections compared with changing infusion set every 4 days.
| Facility | City | Region | Status |
|---|---|---|---|
| La Réunion University Hospital | Saint-Pierre | La Réunion | Not Yet Recruiting |
| Albi Hospital | Albi | France | Not Yet Recruiting |
| Angers University Hospital | Angers | France | Recruiting |
| Belfort Hospital | Belfort | France | Not Yet Recruiting |
| Bourges Hospital | Bourges | France | Not Yet Recruiting |
| Caen University Hospital | Caen | France | Not Yet Recruiting |
| CH Carcassonne | Carcassonne | France | Not Yet Recruiting |
| Chartres Hospital | Chartres | France | Not Yet Recruiting |
| Cholet Hospital | Cholet | France | Not Yet Recruiting |
| Colombes Hospital | Colombes | France | Not Yet Recruiting |
| Corbeil-Essonnes Hospital | Corbeil-Essonnes | France | Not Yet Recruiting |
| AP-HP - Henri Mondor Hospital | Créteil | France | Not Yet Recruiting |
| Dijon University Hospital | Dijon | France | Not Yet Recruiting |
| Garches Hospital | Garches | France | Not Yet Recruiting |
| CH Le Mans | Le Mans | France | Not Yet Recruiting |
| Le Puy en Velay Hospital | Le Puy-en-Velay | France | Not Yet Recruiting |
| Macon Hospital | Mâcon | France | Not Yet Recruiting |
| Nantes University Hospital | Nantes | France | Not Yet Recruiting |
| Orleans University Hospital | Orléans | France | Not Yet Recruiting |
| AP-HP - Tenon Hospital | Paris | France | Not Yet Recruiting |
| AP-HP - Saint Louis | Paris | France | Not Yet Recruiting |
| Pontoise Hospital | Pontoise | France | Not Yet Recruiting |
| CHU Rennes - service MIR | Rennes | France | Not Yet Recruiting |
| CHU Rennes - service Réa chir | Rennes | France | Not Yet Recruiting |
| CH Saint-Nazaire | Saint-Nazaire | France | Not Yet Recruiting |
| Strasbourg University Hospital | Strasbourg | France | Not Yet Recruiting |
| CHU Tours | Tours | France | Not Yet Recruiting |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07183592 on ClinicalTrials.gov ↗ ← All trials in France